
Johnson & Johnson has been offered $4.15 billion by private equity firm The Carlyle Group to buy its Ortho-Clinical Diagnostics …
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations
Alcami appoints Will Isom to lead laboratory services sales

